We are live on ! Find out more
IBB icon

iShares Biotechnology ETF
IBB

624 hedge funds and large institutions have $5.69B invested in iShares Biotechnology ETF in 2017 Q4 according to their latest regulatory filings, with 124 funds opening new positions, 207 increasing their positions, 192 reducing their positions, and 77 closing their positions.

New
Increased
Maintained
Reduced
Closed

61% more first-time investments, than exits

New positions opened: 124 | Existing positions closed: 77

7% more funds holding

Funds holding: 583 → 624 (+41)

8% more repeat investments, than reductions

Existing positions increased: 207 | Existing positions reduced: 192

0% more funds holding in top 10

Funds holding in top 10: 30 → 30 (0)

12% less capital invested

Capital invested by funds: $6.44B → $5.69B (-$749M)

57% less call options, than puts

Call options by funds: $533M | Put options by funds: $1.25B

127.95% less ownership

Funds ownership: 186.53% → 58.57% (-128%)

Holders
624
Holders Change
+41
Holders Change %
+7.03%
% of All Funds
14.15%
Holding in Top 10
30
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.68%
New
124
Increased
207
Reduced
192
Closed
77
Calls
$533M
Puts
$1.25B
Net Calls
-$712M
Net Calls Change
-$479M

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$114M
2
Citigroup
Citigroup
New York
+$57.5M
3
Two Sigma Advisers
Two Sigma Advisers
New York
+$31.4M
4
Two Sigma Investments
Two Sigma Investments
New York
+$26.2M
5
ACI
AMP Capital Investors
Australia
+$25.7M

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$169M
2
Goldman Sachs
Goldman Sachs
New York
-$139M
3
N
Natixis
France
-$95.4M
4
AllianceBernstein
AllianceBernstein
Tennessee
-$81.8M
5
JP Morgan Chase
JP Morgan Chase
New York
-$70.7M
Name Holding Trade Value Shares
Change 		Change in
Stake
QIM
626
Quantitative Investment Management
Virginia
– -$39.7M -357,300 Closed
DFO
627
Duquesne Family Office
New York
– -$36.9M -332,100 Closed
Federated Hermes
628
Federated Hermes
Pennsylvania
– -$36.1M -324,900 Closed
JCM
629
Janney Capital Management
Pennsylvania
– -$35.3M -317,385 Closed
MSWM
630
Mader & Shannon Wealth Management
Missouri
– -$7.7M -69,270 Closed
MP
631
Manifold Partners
California
– -$7.08M -63,678 Closed
Susquehanna International Group
632
Susquehanna International Group
Pennsylvania
– -$4.87M -45,525 Closed
Simplex Trading
633
Simplex Trading
Illinois
– -$3.86M -34,680 Closed
CCMG
634
Clark Capital Management Group
Pennsylvania
– -$3.61M -32,496 Closed
PWPCM
635
Perella Weinberg Partners Capital Management
New York
– -$2.44K -21,903 Closed
TFA
636
Transamerica Financial Advisors
Florida
– -$2.43M -21,873 Closed
GCA
637
Greenwood Capital Associates
South Carolina
– -$2.37M -21,348 Closed
SC
638
Selz Capital
New York
– -$2.33M -21,000 Closed
SPM
639
Symmetry Peak Management
Pennsylvania
– -$2.33M -21,000 Closed
GIM
640
Guild Investment Management
California
– -$2.33M -20,970 Closed
ACM
641
Aviance Capital Management
Florida
– -$2.31M -20,817 Closed
UM
642
Ulysses Management
New York
– -$2M -18,000 Closed
JAM
643
JW Asset Management
Florida
– -$1.94M -17,484 Closed
PSW
644
Portfolio Strategies (Washington)
Washington
– -$1.87M -16,809 Closed
MWVC
645
Morgens Waterfall Vintiadis & Co
New York
– -$1.5M -13,500 Closed
SFG
646
SNS Financial Group
Minnesota
– -$1.37M -12,288 Closed
ACM
647
Alethea Capital Management
Washington
– -$1.27M -11,385 Closed
Nomura Asset Management
648
Nomura Asset Management
Japan
– -$1.21M -10,893 Closed
BFM
649
Boothbay Fund Management
New York
– -$1.17M -10,500 Closed
RCP
650
Rothschild Capital Partners
New York
– -$1.05M -9,468 Closed
24 25
26
27 28

IBB Hedge Fund Activity: Q4 2017 in Review

624 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in iShares Biotechnology ETF (IBB) for Q4 2017, worth a combined $5.69B — down 12% from $6.44B a quarter earlier.

Buyers outnumbered sellers: 124 funds opened new IBB positions and 77 closed out — a net gain of 47 holders — while 207 added to existing stakes and 192 trimmed.

The largest buyer was UBS Group, adding an estimated $114M. The largest seller was Morgan Stanley, cutting an estimated $169M.

  • 624 institutional investors held iShares Biotechnology ETF (IBB) as of Q4 2017, up from 583 in Q3 2017.
  • Funds reported $5.69B of iShares Biotechnology ETF stock for Q4 2017, down 12% quarter-over-quarter.
  • 124 funds opened new iShares Biotechnology ETF positions in Q4 2017 and 77 closed out, a net change of +47 holders.
  • The largest iShares Biotechnology ETF buyer in Q4 2017 was UBS Group, an estimated $114M added.
  • The largest iShares Biotechnology ETF seller in Q4 2017 was Morgan Stanley, an estimated $169M sold.

Based on aggregated 13F filings for Q4 2017.